Patent 7994328 was granted and assigned to Aurobindo Pharma on August, 2011 by the United States Patent and Trademark Office.
The present invention relates to an improved process for the preparation of 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride of Formula I.